The Haemodynamic Significant Patent Ductus Arteriosus (PDA) in preterm infants: significance of different echocardiographic markers, clinical signs, Near Infrared Spectroscopy (NIRS) and B-type Natriuretic Peptide (BNP).

The Haemodynamic Significant Patent Ductus Arteriosus (PDA) in preterm infants: significance of different echocardiographic markers, clinical signs, Near Infrared Spectroscopy (NIRS) and B-type Natriuretic Peptide (BNP). - Significant PDA: echocardiography, NIRS, BNP and clinical signs

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33822

Enrollment

250

Registered

2009-08-25

Start date

2009-10-08

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

open Ductus Botalli (ODB) persisting connection between pulmonary artery and systemic artery

Interventions

None listed

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Preterm babies born before 32 weeks of gestation admitted to the NICU of the WKZ/UMCU

Exclusion criteria

Exclusion criteria: Preterm babies with congenital cardiac malformations, chromosomal abnormalities or gross cerebral congenital abnormalities

Design outcomes

Primary

Measure	Time frame
With respect to PDA in preterm infants	—

Secondary

Measure	Time frame
1. normal range of left and right ventricular dimensions in preterm infants	—

Countries

Netherlands

Outcome results